Summaries of peer-reviewed research for compounds in our catalogue. Each article references published studies from leading scientific journals with direct links to original papers.
The following summaries are provided for educational and informational purposes only. They reference published peer-reviewed research and do not constitute medical advice, treatment recommendations, or health claims. All products sold by Neovia Peptides are intended strictly for in-vitro research and laboratory use. Researchers should consult the original publications for complete methodology and findings.
Examining the molecular pharmacology, clinical evidence, and emerging research directions of the acylated GLP-1 analogue semaglutide
A comprehensive review of the pharmacology, mechanism of action, and clinical research landscape of the first dual incretin receptor agonist
Comprehensive review of preclinical rationale, clinical trial outcomes, and the pharmacology of triple incretin receptor agonism
Examining the pharmacology, mechanism of action, clinical trial evidence, and emerging research directions of the acylated amylin analogue cagrilintide
A comparative synthesis of peer-reviewed literature on single (GLP-1), dual (GLP-1/GIP) and triple (GLP-1/GIP/glucagon) incretin receptor agonists, with amylin co-agonism context, examining receptor pharmacology and what trial literature reports for each class.
Examining the molecular mechanisms, pharmacological properties, and preclinical evidence for Body Protection Compound-157 across tissue repair, gastrointestinal protection, and wound healing models.
A comprehensive review of the actin-sequestering peptide and its role in cell migration, wound healing, and cardiac repair research
A comparative summary of the published preclinical literature on three peptides that recur in tissue-repair research — BPC-157, TB-500 (thymosin β4) and the copper tripeptide GHK-Cu — outlining their distinct reported mechanisms and the largely animal-model and in-vitro nature of the evidence.
A comprehensive review of NAD+ biochemistry, its decline during aging, and emerging research into sirtuin activation and DNA repair pathways
Surveying the biochemical properties, copper-binding mechanisms, and preclinical evidence for glycyl-L-histidyl-L-lysine copper(II) complex across skin regeneration, wound healing, and anti-inflammatory research models.
Examining the molecular basis, preclinical evidence, and current research directions for the synthetic tetrapeptide Ala-Glu-Asp-Gly in telomere biology, pineal gland function, and aging-related models.
A review of the structural basis, inner membrane targeting mechanism, and preclinical and clinical evidence for SS-31 across mitochondrial dysfunction, cardiac, and renal disease models.
A review of the molecular pharmacology, receptor selectivity, pharmacokinetic profile, and preclinical evidence for ipamorelin in growth hormone secretion, bone mineral density, and gastrointestinal function models.
A review of the structure, pharmacokinetics, and preclinical and clinical evidence for CJC-1295 with and without Drug Affinity Complex, including mechanisms of GH pulsatility modulation and IGF-1 elevation.
A comprehensive review of the molecular pharmacology, receptor binding kinetics, clinical investigation in growth hormone deficiency, pharmacokinetic properties, and comparative analysis with structurally related GHRH analogues.
A review of the pharmacology, oral bioavailability, clinical evidence for GH and IGF-1 modulation, body composition effects, sleep architecture changes, and current research directions for the ghrelin mimetic ibutamoren mesylate.
A comprehensive review of tesamorelin's molecular structure, GHRH receptor pharmacology, and published research spanning HIV-associated lipodystrophy, hepatic steatosis, and cognitive function.
Examining the molecular mechanisms, TGF-β superfamily antagonism, and preclinical evidence for Follistatin 344 across skeletal muscle regulation, reproductive biology, and gene therapy applications.
Examining the structural modifications, receptor pharmacology, and preclinical evidence for Long R3 IGF-1 across cell proliferation, skeletal muscle biology, and emerging research applications.
A comparative summary of published peer-reviewed research on growth hormone secretagogues, contrasting growth-hormone-releasing-hormone (GHRH) analogues with ghrelin-receptor agonists and non-peptide compounds at the level of reported mechanism and experimental findings.
A review of the molecular pharmacology, neurotrophic signalling mechanisms, and preclinical evidence for the heptapeptide Semax across models of neurodegeneration, cognitive function, and cerebrovascular injury.
A review of the molecular pharmacology, GABAergic modulation, enkephalinase inhibition, and preclinical anxiolytic and immunoregulatory research surrounding the heptapeptide Selank (TP-7).
A review of the medicinal chemistry, hepatocyte growth factor/MET receptor potentiation, synaptogenic activity, blood-brain barrier penetration, and preclinical cognitive research surrounding the hexapeptide analogue Dihexa (N-hexanoic-Tyr-Ile-(6) aminohexanoic amide).
A literature review of the published preclinical and clinical research on three neuroactive peptides — Semax, Selank and Dihexa — with a focus on their reported molecular mechanisms in neurotrophin signalling, GABAergic modulation and synaptogenesis. For in-vitro and laboratory research use only.
Examining the lipolytic mechanism, metabolic profile, and emerging cartilage repair applications of the C-terminal growth hormone fragment AOD-9604, with consideration of its dissociation from somatotropic activity.
A review of the biochemical rationale, preclinical evidence, and emerging research directions for 5-Amino-1MQ as a nicotinamide N-methyltransferase inhibitor
A literature review of two distinct classes of mitochondrial peptide — the mitochondrial-derived peptide MOTS-c and the cardiolipin-binding tetrapeptide SS-31 (elamipretide) — examining their reported molecular mechanisms in published in-vitro and preclinical models.
Examining the molecular mechanisms, NF-κB modulatory activity, and preclinical evidence for the alpha-melanocyte-stimulating hormone-derived tripeptide KPV across inflammatory bowel disease, antimicrobial, and immunomodulatory research models.
Examining the role of kisspeptin signalling via the KISS1R/GPR54 receptor in gonadotropin-releasing hormone regulation, puberty onset, and reproductive biology across preclinical and clinical models.
Examining the pharmacology, receptor selectivity, clinical research, and investigational potential of bremelanotide as a synthetic melanocortin peptide acting through MC3R/MC4R pathways.
Examining the structure, membrane-disruptive mechanisms, immunomodulatory signalling, chemotactic activity, and preclinical evidence for the sole human cathelicidin LL-37 across antimicrobial, wound repair, and innate immune research models.
Examining the molecular mechanisms, dendritic cell maturation, T-cell differentiation, and clinical evidence for thymosin alpha-1 across hepatitis B treatment, vaccine adjuvant research, and emerging immunological applications.
Examining the glycoprotein hormone structure, LH/CG receptor agonism, steroidogenic signalling cascades, and investigational roles in reproductive biology, Leydig cell function, and pregnancy maintenance.
A comprehensive review of MOTS-c research examining its origins as a mitochondrial open reading frame peptide, AMPK-dependent signalling mechanisms, interactions with the folate-methionine cycle, and emerging preclinical evidence for exercise mimetic and metabolic regulatory properties.
A comprehensive review of SLU-PP-332 research examining its development as a pan-ERR agonist, mechanisms of action through ERRα and ERRγ activation, effects on mitochondrial biogenesis and fatty acid oxidation, preclinical evidence for exercise mimetic properties including muscle fibre type switching, and current research directions.
View all research-grade peptides with certificates of analysis and purity data.
